Use of anti-idiotypic antibody-drug conjugates to treat experimental murine B-cell tumors.
Hurwitz
E
E
Haimovich
J
J
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000276:immunology; D002945:Cisplatin / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D007075:Immunoglobulin M; D008223:Lymphoma / Q000188:drug therapy*; D051379:Mice; D014407:Tumor Cells, Cultured / Q000166:cytology / Q000187:drug effects
D000888:Antibodies, Anti-Idiotypic; D000970:Antineoplastic Agents; D007075:Immunoglobulin M; D003561:Cytarabine; D004317:Doxorubicin; D002945:Cisplatin; D003630:Daunorubicin